Skip to main content
Home
Advertise with Us
News Sections
Academic Research
AI/Machine Learning
Analytics & Data Science
Clinical IT
Cybersecurity & Privacy
Editor's Picks & Featured Content
Hospital Systems & Operations
Government
Imaging
Industry Perspectives
Interoperability/HIE
Population Health Management
Q&A
Revenue Cycle Management & Finance
White Papers
Premium Articles
Achieving value-based care through the supply chain
Why Partnerships are Key to Driving Healthcare Forward
Books & Publications
Healthcare IT Conferences and Events
Contact
Menu
Home
Advertise with Us
News Sections
Academic Research
AI/Machine Learning
Analytics & Data Science
Clinical IT
Cybersecurity & Privacy
Editor's Picks & Featured Content
Hospital Systems & Operations
Government
Imaging
Industry Perspectives
Interoperability/HIE
Population Health Management
Q&A
Revenue Cycle Management & Finance
White Papers
Premium Articles
Achieving value-based care through the supply chain
Why Partnerships are Key to Driving Healthcare Forward
Books & Publications
Healthcare IT Conferences and Events
Contact
Editor’s Choice
Apple’s Latest Wearables Escalate the Medicalization of Consumer Tech
Apple’s recent launch of the Watch Series 11 and AirPods Pro 3 introduces more than incremental hardware updates. By embedding heart rate sensing into earbuds and promising hypertension detection via smartwatch, the company has signaled a deeper ambition: to collapse the boundary between lifestyle tech and regulated medical oversight.
CPT 2026 Signals Strategic Pivot Toward AI, Digital Monitoring, and Value-Based Precision
The American Medical Association (AMA) has released the CPT 2026 code set, introducing 288 new procedural codes that reflect the accelerating convergence of technology, clinical innovation, and reimbursement strategy in American healthcare. While often viewed through a billing and administrative lens, the CPT framework has evolved into a critical policy lever, defining what care is measurable, billable, and therefore deliverable at scale.
Photo 204419407 / Ama © Alena Zharava | Dreamstime.com
FDA Prepares to Tackle Oversight of AI-Enabled Mental Health Devices
The U.S. Food and Drug Administration (FDA) has scheduled a pivotal advisory committee meeting for November 6 to address the regulatory future of AI-powered digital mental health tools. Convened under the auspices of the agency’s Digital Health Advisory Committee (DHAC), the session will explore how emerging technologies, from chatbots to algorithmic screening tools, might bridge gaps in behavioral health access, while also surfacing unique safety and oversight challenges.
Photo 204419407 / Ama © Alena Zharava | Dreamstime.com
Kaiser Permanente Expanding to Nevada with Renown Health Partnership
In a move that redefines the competitive landscape of Nevada’s healthcare market, Kaiser Permanente and Renown Health have announced a joint venture that will combine Kaiser’s nationally scaled value-based care model with Renown’s regional insurance infrastructure and care delivery footprint. Beginning in 2026, the two organizations will co-own and operate a health plan and outpatient care system in northern Nevada under the newly formed Kaiser Permanente Nevada.
Rural Hospitals Face Renewed Threats as Medicaid Payment Caps Loom
A new federal law, passed under the Trump administration’s 2025 tax and spending legislation, is poised to reconfigure the financial bedrock of the Medicaid program. Tucked inside the sweeping One Big Beautiful Bill Act is a policy shift that will cap state-directed Medicaid payments to hospitals and physicians which are cuts that, according to provider groups and state hospital associations, could devastate already-fragile rural health systems.
Jeanne Cohen and Motive Medical Intelligence on Physician-Level Precision in Value-Based Care
As the healthcare industry recalibrates its ambitions for value-based care (VBC), one reality has grown increasingly difficult to ignore: aggregate data isn’t enough. Executives and clinical leaders charged with reducing costs and improving outcomes have long relied on population-level metrics and episode-based models to guide transformation. But when avoidable variation in care still accounts for hundreds of billions in waste, a shift in measurement strategy becomes essential.
Verily’s Strategic Retreat from Devices Signals Alphabet’s All-In AI Bet
Alphabet’s Verily has officially shuttered its medical device division, marking a significant realignment of the company’s once-celebrated healthcare ambitions. In doing so, Verily joins a growing list of tech-backed health ventures that are stepping away from hardware-driven innovation in favor of AI-centric strategies with faster return potential.
OpenAI’s Healthcare Play
OpenAI is no longer content to merely power third-party healthcare tools behind the scenes. With a deliberate shift in strategy and a growing leadership roster pulled from both Silicon Valley and digital health, the company is now building and launching its own healthcare applications. This move signals a transition from infrastructure provider to direct actor, one with intentions to shape both patient-facing and clinical decision-making platforms across care delivery.
Emory Lawsuit Spotlights Broader Transparency and Risk Questions in Healthcare Workforce Restructuring
A proposed class action lawsuit against Emory Healthcare over recent finance department layoffs is generating scrutiny not just for its legal claims, but for what it reveals about labor transparency, severance practices, and operational risk management in the hospital sector.
Stanford Health: Precision Drug Delivery Will Test the Boundaries of Noninvasive Therapeutics
The long-standing paradox of modern pharmacology is that the more powerful a drug becomes, the harder it is to contain. Psychiatric medications, anesthetics, and chemotherapeutics often produce life-altering effects, both therapeutic and toxic, because the body does not allow for localization. Drugs circulate systemically, binding wherever biology allows, whether needed or not.
Inner Speech BCIs Are Reframing the Future of Communication
Emerging research from Stanford Medicine marks a significant inflection point in brain-computer interface (BCI) development. Rather than simply decoding attempted movements or vocalizations, scientists have demonstrated the ability to capture and interpret inner speech, the silent, imagined articulation of words that occurs within the mind.
Anxiety Measurement Enters the Biometrics Era. But Validation Remains the Barrier.
NuraLogix’s launch of its Anura Anxiety Index signals an ambitious pivot in digital mental health: the attempt to quantify long-term anxiety through physiological signals alone.
Tech Giants Can’t Innovate Their Way Around IP Accountability
Apple’s newly redesigned blood oxygen feature is less a story of technological advancement than a case study in regulatory adaptation. After a protracted legal dispute with medical device firm Masimo, the tech giant has resumed functionality on certain Apple Watch models, this time through a modified version of the feature that attempts to sidestep ongoing intellectual property conflicts
Browser Control Is Now A Health Safety Issue
Perplexity’s surprise offer to buy Chrome reads like a tech-world stunt, yet the episode underscores a quieter reality for healthcare: whoever controls a dominant browser shapes how patients encounter clinical information, payer rules, and provider access. The first screen a consumer sees is increasingly an AI-mediated summary, not an official portal.
Solving Asset Management, Utilization, and Workflow Challenges with RTLS
One of the most persistent challenges affecting hospital efficiency is equipment loss and underutilization. Studies suggest that nurses can spend up to an hour each shift searching for medical devices, and hospitals often over-purchase by 10–20% to compensate for misplaced assets.